How Do Early Phase Oncology Trials Evolve?

How Do Early Phase Oncology Trials Evolve?

In the last few years, a major breakthrough in cancer research has occurred: early phase oncology trials. This type of trial is designed to test whether a new drug has any adverse effects on people and also provides anecdotal evidence that it might be efficacious. This blog post will discuss the...

read more
Artificial Intelligence in Pharmacovigilance

Artificial Intelligence in Pharmacovigilance

Automation & AI in Pharmacovigilance: Promises and Realistic Expectations Recent years have seen increasing pharmaceutical companies' pharmacovigilance (PV)-related activities. The promise of artificial intelligence (AI) and automation is often mentioned as a way to meet the increasing PV...

read more
How to Avoid Delays in Your Early Phase Oncology Trial?

How to Avoid Delays in Your Early Phase Oncology Trial?

Webinar: How to Avoid Delays in Your Early Phase Oncology Trial? Many things can go array in your early phase oncology trials, from protocol development, taking care of a safety profile, getting the ethics committee / regulatory authority’s approval, managing vendors, and much more. They all cost...

read more
Pharmacovigilance Opportunities in the MENA Region

Pharmacovigilance Opportunities in the MENA Region

Webinar: Pharmacovigilance Opportunities in the MENA Region Pharmacovigilance is getting more and more attention in MENA countries thanks to new regulations and steps in the right direction. The MENA region itself holds great promise for the pharmaceutical industry, being potentially hugely...

read more
Pharmacovigilance in the MENA Region

Pharmacovigilance in the MENA Region

This blog focuses on pharmacovigilance (PV) in the MENA Region; the Middle East and North Africa. We do this by comparing the MENA region and Europe and inter-country differences in the MENA region. Local legislation and requirements will be discussed, such as requirements on periodic safety...

read more
Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database

Selecting a Pharmacovigilance Drug Safety Database The WHO defines pharmacovigilance (PV) as the science and activities related to detecting, assessing, understanding, and preventing adverse effects of a medicinal product or any other possible drug-related problems. A drug safety database is a...

read more
How does the Russian invasion impact the pharmaceutical industry?

How does the Russian invasion impact the pharmaceutical industry?

Like the rest of the world, the pharmaceutical and biotech industries are beginning to worry about their ability to continue operations. And, with good reason. Russia's invasion of Ukraine affects millions of people, not just in this Eastern European nation but throughout the world. As a result,...

read more
How To Manage An Early Phase Oncology Study: Project Manager Insights

How To Manage An Early Phase Oncology Study: Project Manager Insights

Clinical development of oncology drugs has one of the lowest success rates of the development of Investigational New Drugs (INDs) for all disease categories, with less than 7% of phase I-tested oncology drugs achieving market approval. Moreover, the clinical development time for medicinal oncology...

read more
Biomapas Announces Two New Appointments to Board of Directors

Biomapas Announces Two New Appointments to Board of Directors

February 2022 Biomapas, a full spectrum clinical, regulatory, pharmacovigilance and medical information solution provider, is pleased to announce the two new members joining its board of directors. Coming from life science, biopharmaceutical and financial industries, they bring years of experience...

read more
How To Improve Patient Recruitment In Early Phase Oncology Trials

How To Improve Patient Recruitment In Early Phase Oncology Trials

The difficulties of recruiting in clinical trials, and particularly cancer patients in their early stages, can significantly obstruct the development of innovative treatments. There is an undeniable increase in demand for Early Phase Clinical studies in patients to enable informed decision-making....

read more
What are the advantages of a hospital-based Early Phase Unit?

What are the advantages of a hospital-based Early Phase Unit?

Choosing the right setting for your early phase trial can be challenging. As a sponsor, it's natural to remain cautious about running more extensive early-phase patient trials in a single Phase I unit due predominantly to the doubt over actually being able to recruit large patient populations....

read more